PlainRecalls
FDA Drug Low Class III Terminated

Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-723-10

Reported: November 13, 2019 Initiated: November 1, 2019 #D-0305-2020

Product Description

Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-723-10

Reason for Recall

Presence of Foreign substance: identified as a dead ant.

Details

Units Affected
30,516 bottles
Distribution
Product was distributed to major distributors/wholesalers throughout the United States.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-723-10. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 30,516 bottles.
Why was this product recalled?
Presence of Foreign substance: identified as a dead ant.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 13, 2019. Severity: Low. Recall number: D-0305-2020.